Bottom line
How much do ETHSX and QAAGZX overlap?
64% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 57.9% of ETHSX's assets and 52.0% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.
QAAGZX holds far more positions (277 vs 42), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings ETHSX and QAAGZX have in common
| Holding | % of ETHSX | % of QAAGZX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 12.47% | 14.06% | 12.47% |
| AbbVie Inc | 6.46% | 5.12% | 5.12% |
| Johnson & Johnson | 6.45% | 6.64% | 6.45% |
| UnitedHealth Group Inc | 5.49% | 5.88% | 5.49% |
| Merck & Co Inc | 5.08% | 4.00% | 4.00% |
| Bristol-Myers Squibb Co | 4.25% | 2.12% | 2.12% |
| Vertex Pharmaceuticals Inc | 3.38% | 2.26% | 2.26% |
| Gilead Sciences Inc | 3.34% | 2.79% | 2.79% |
| Thermo Fisher Scientific Inc | 2.79% | 2.53% | 2.53% |
| Intuitive Surgical Inc | 2.72% | 1.89% | 1.89% |
| Stryker Corp | 2.21% | 1.78% | 1.78% |
| Abbott Laboratories | 1.65% | 1.91% | 1.65% |
| Royalty Pharma PLC | 1.58% | 0.97% | 0.97% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in ETHSX
- AstraZeneca PLC — 6.24%
- Roche Holding AG — 5.44%
- Sanofi SA — 2.95%
- Boston Scientific Corp — 2.18%
- Medtronic PLC — 1.80%
- Lonza Group AG — 1.77%
- Novo Nordisk A/S — 1.71%
- Novartis AG — 1.65%
- Argenx SE — 1.61%
- Neurocrine Biosciences Inc — 1.41%
- Mettler-Toledo International Inc — 1.36%
- Straumann Holding AG — 1.34%
Only in QAAGZX
- Amgen Inc — 1.80%
- Elevance Health Inc — 1.54%
- Danaher Corp — 1.44%
- Natera Inc — 1.44%
- Guardant Health Inc — 1.22%
- Cardinal Health Inc — 1.04%
- Tenet Healthcare Corp — 0.94%
- Cvs Health Corp — 0.93%
- Kymera Therapeutics Inc — 0.89%
- T. Rowe Price Government Reserve Fund — 0.87%
- Protagonist Therapeutics Inc — 0.85%
- Moderna Therapeutics Inc — 0.83%
Asset mix
| Asset type | ETHSX | QAAGZX |
|---|---|---|
| Stocks | 99.4% | 96.9% |
| Preferred stock | — | 2.2% |
| Cash & short-term funds | 0.3% | 0.9% |
| Bonds | — | 0.1% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Country mix
| Country | ETHSX | QAAGZX |
|---|---|---|
| US | 69.4% | 92.3% |
| CH | 10.2% | 0.5% |
| GB | 7.8% | 1.8% |
| FR | 3.2% | 0.3% |
| DK | 2.9% | 0.7% |
| NL | 2.0% | 1.0% |
| IE | 1.8% | 0.8% |
| AU | 0.9% | — |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do ETHSX and QAAGZX overlap?
What stocks do ETHSX and QAAGZX have in common?
Should I own both ETHSX and QAAGZX?
Which holds more stocks, ETHSX or QAAGZX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.